Yafang Huang

10PUBLICATIONS
3CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 19, 2026
Design Characteristics and Survival Outcomes of Local Trials Supporting the Approval of Targeted Anticancer Drugs in China.

|Apr 19, 2026
Epidemiological Characteristics, Target Distribution, and Clinical Value of Targeted Anticancer Drugs Approved in China: A Cross-Sectional Study.

|Apr 03, 2026
Clinical Benefit and Global Regulation of Bispecific Antibody Drugs: A Cross-sectional Analysis.

Renjie Wang, Ting Zhu, Yafang Huang

|Aug 01, 2025
Using Dose-Escalation and -Expansion Cohort Study as Pivotal Trial for Targeted Anticancer Drug Approval.

Yafang Huang, Ting Zhu, Jinjia Zhong

|Jun 05, 2025
Reporting quality of dose-expansion cohorts in trials of anticancer drugs could be improved: a cross-sectional study.

Yafang Huang, Jinjia Zhong, Ting Zhu

|Apr 15, 2025
Cancer Drugs Approved Based on Surrogate Endpoint: A Retrospective Observational Study in the United States and China.

Ting Zhu, Jinjia Zhong, Yafang Huang

Pageof 2

Frequent Collaborators

2 joint publications

Ting Zhu

1 joint publications

Jinjia Zhong

1 joint publications

Renjie Wang